670 search results for “development disease” in the Student website
-
Ili MaFaculty of Social and Behavioural Sciences
-
Shruti Jain -
George Miley -
Arnout KoornneefFaculty of Social and Behavioural Sciences
-
Marianne van Dijken
Faculty of Social and Behavioural Sciences
-
Nienke WieringaICLON
-
Kiki Spaninks -
Jennifer Anderson -
Tommy van AvermaeteLeiden University Libraries
-
Eline DekeysterFaculty of Social and Behavioural Sciences
-
Stephan VerschoorFaculty of Social and Behavioural Sciences
-
Lotte Nagelhout -
Frits Rosendaal -
Coen van Hasselt -
Frank Schaftenaar -
Paul Hooykaas -
Anna van DuijvenvoordeFaculty of Social and Behavioural Sciences
-
Sheila van BerkelFaculty of Social and Behavioural Sciences
-
David ZetlandFaculteit Governance and Global Affairs
-
Evelien UrbanusFaculty of Social and Behavioural Sciences
-
Christine Mummery -
Hanna Swaab
Faculty of Social and Behavioural Sciences
-
How these young researchers are preparing for their first scientific conference
Three Psychology students will present a poster of their thesis research on Alzheimer’s and dementia at the international conference AAIC Neuroscience Next. ‘I remind myself to recognise - without fear or shame - when I don't know something.’
-
Costanza FranceschiniFaculty of Social and Behavioural Sciences
-
Diego Barbosa Arize SantosFaculty of Social and Behavioural Sciences
-
Nikki NibberingFaculty of Social and Behavioural Sciences
-
Esther MertensFaculty of Social and Behavioural Sciences
-
Kees Musters -
Annemarie Meijer -
Shannon YuenFaculty of Social and Behavioural Sciences
-
Maria Gabriela Palacio LudeñaFaculty of Humanities
-
Marleen DekkerAfrika-Studiecentrum
-
Marnix Medema -
Investigating inflammation: new leads for treating atherosclerosis
How do you detect people at high risk of heart attacks and strokes? And how can we improve the treatment of atherosclerosis? These are the questions that keep LACDR researcher Marie Depuydt busy. She is investigating the immune cells that contribute to the worsening of atherosclerosis. ‘It's a challenging…
-
Sustainability & Development MSc Policy in Practice | Leiden University
Research Internships in the field of Sustainability and Development focus on the challenges presented by the need to find ways in which consumption, usage, production, recycling and reusage can be brought in line with current societal needs. The Research Internships included in this category are being…
-
Veronique de GuchtFaculty of Social and Behavioural Sciences
-
Graduation ceremony bachelor programme Cultural Anthropology and Development Sociology
Festival, Graduation Ceremony
-
Kim Stroet
Faculty of Social and Behavioural Sciences
-
Stewart McDowall -
Greater understanding of specialised cell could prevent strokes
Ilze Bot wants to reduce the prevalence of cardiovascular diseases. Her research focuses on mast cells, which protect us from infections but can also make us ill.
-
New easy-to-use tuberculosis vaccine patch in development
Researchers from Leiden have developed a promising TB vaccine that users can self-administer via a special patch. This could be beneficial for countries with limited health services, says PhD candidate Malene Neustrup.
-
Stephanus HuijbregtsFaculty of Social and Behavioural Sciences
-
Herman Spaink -
The right diagnosis and faster for women with heart problems
It often takes longer for women with heart problems to get the right diagnosis. In her Annie Romein-Verschoor Lecture, Professor Hester den Ruijter will talk about how hormones influence the heart and the importance of medical research that focuses specifically on women.
-
Caroline ArchambaultFaculteit Governance and Global Affairs
-
Rehana DoleFaculteit der Rechtsgeleerdheid
-
Eva SchmidtFaculteit der Rechtsgeleerdheid
-
Edmund AmannFaculty of Humanities
-
Vivian Kraaij
Faculty of Social and Behavioural Sciences
-
Leiden-developed drug candidate ready for final clinical trial phase
Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.